期刊文献+

埃索美拉唑治疗胃食管反流病的临床观察 被引量:2

Esomeprazole in gastroesophageal reflux disease
下载PDF
导出
摘要 目的探讨不同剂量埃索美拉唑对胃食管反流病(GERD)的治疗效果。方法选择63例门诊及住院经电子胃镜证实为GERD患者(洛杉矶分级为A级和B级)随机分为三组。A组20例予以埃索美拉唑20mg,每日2次;B组21例予以埃索美拉唑40mg,每日2次;C组22例予以埃索美拉唑20mg,每日2次,睡前40mg,分别观察患者治疗前及治疗后8周临床症状改善情况;治疗8周后行电子胃镜检查观察愈合率。结果三组临床症状均有明显改善,症状记分较治疗前显著下降(P均<0.01)。C组在症状消失率、总有效率以及内镜下食管炎愈合率和总有效率方面均高于A、B组,但差异无显著性。结论埃索美拉唑是治疗轻、中度GERD患者有效的药物,尤其加用夜间酸突破治疗,效果更佳。 Objective To compare clinical efficacy of different dosage of Esomeprazole in treatment of gastroesophageal reflux disease (GERD). Methods Sixty - three patients with GERD proven by gastroscope were enrolled in this study. They were randomly allocated to three groups, group A, B and C. Twenty cases in group A received therapy with Esomeprazole 20mg, twice a day; twenty - one cases in group B were given Esomeprazole 40mg, twice a day; twenty- two cases in group C were given Esomeprazole 20mg, twice a day, 40mg before night sleeping. Before treatment and 8 weeks after treatment, the clinical symptoms and signs were assessed, 8 weeks after the treatment, a gastroscope was used to examine the healing state. Results Symptom relief was obtained in all the three groups, by comparison to treatment before, the symptom scores were lower ( P 〈0. 01 ). In comparison to groups A and B, higher symptom free rate, total effective rate, and endoscopic esophogitis healing rate and total effective rate were found, but there were no statistically significant differences. Conclusion Esomeprazole is an effective drug in treatment of mild, moderate GERD, a better result was obtained plus nocturnal acid breakthrough treatment.
出处 《右江民族医学院学报》 2006年第3期360-362,共3页 Journal of Youjiang Medical University for Nationalities
关键词 胃食管反流饴疗 埃索美拉唑 剂量效应关系 药物 gastroesophageal reflux/therapy esomeprazole dose - response relationship
  • 相关文献

参考文献7

  • 1Heudebert GR,Marks K,Wilcox CM,et al.Choice of long-term strategy for the managemnt of patients with severe esophagitis:a cost-utility analysis[J].Gastroenterology,1997,112(4):1078-1086.
  • 2钟捷.埃索美拉唑与兰索拉唑治疗糜烂性食管炎疗效比较[J].中华消化杂志,2003,23(6):366-367. 被引量:17
  • 3Hassan-Alin M,Andersson T,Rohas K,et al.Pharrmacokinectics(PK) and does response relationship of esomeprazole[Abstract][J].Castroentemlogy,2000,118:A5550.
  • 4Katsube T,Adachi K,Kawamura A,et al.Helicobacter pylori infection influences nocturnal gastric acid breakthrough[J].Aliment Pharmacol Ther,2000,14(8):1049-1056.
  • 5Hatlebakk JG,Katz PO,Kuo B,et al.Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily[J].Aliment Pharmacol The,1998,12(12):1235-1240.
  • 6Kinoshita Y,Kawanami C,Kishi K,et al.Helicobacter Hpylori independent chronological change in gastric acid secretion in the Japanese[J].Gut,1997,41(4):452-458.
  • 7van Herwaarden MA,Samsom M,Smout AJ.Helicobacter pylori eradication increases nocturnal acid breakthrough[J].Aliment Pharmacol Ther,2000,14(7):961-962.

共引文献16

同被引文献1

  • 1Klotz U, Schwab M, Treiber G. CYP2C19 Polymorphism and Proton Pump Inhibitors[J]. Basic Clin Pharmacol Toxicol, 2004, 95(1) :2- 8.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部